AstraZeneca has signed an AI-led research agreement with China’s CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic ...

New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted Innovation and Strategic Growth ...

Shares of AstraZeneca Pharma India, Max Healthcare, Manappuram Finance, Muthoot Finance and JK Cement have touched fresh ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

Upstream Bio (UPB) shares saw an increase in after-hours trading on Friday following the company's presentation of ...